Product Description
| Brand | Zybio |
| Sample Type | Plasma |
| Pack Size | 1 x 100T |
| CAT No | 01.09.49.08.01.02 |
Application | Tumor Marker |
ZYBIO ProGRP (CLIA) reagent kit is designed for accurate quantitative determination of Pro-Gastrin-Releasing Peptide (ProGRP) levels using chemiluminescent immunoassay technology.
Advanced Chemiluminescence TechnologyLeveraging the Chemiluminescence Immunoassay (CLIA) technique, the ZYBIO EXI ProGRP analyzer provides high specificity and sensitivity in the determination of ProGRP. This technology ensures that laboratory professionals receive consistent and accurate diagnostic results for improved patient care.
Convenient and Portable DesignDesigned to be portable and user-friendly, the ZYBIO EXI ProGRP (CLIA) fits seamlessly into diverse laboratory setups. The automatic operation reduces manual intervention, while real-time data output enhances workflow efficiency in high-throughput environments.
Optimal Storage and MaintenanceThe analyzer and its reagents should be stored at a controlled temperature of 2 to 8C to maintain performance integrity. Adhering to these storage conditions prolongs equipment lifespan and ensures ongoing accuracy in test results.
FAQ's of ZYBIO EXI ProGRP (CLIA):
Q: How does the ZYBIO EXI ProGRP (CLIA) analyzer function in clinical laboratories?
A: The ZYBIO EXI ProGRP (CLIA) analyzer uses Chemiluminescence Immunoassay technology to automatically detect and quantify ProGRP levels in patient samples, helping clinicians make informed diagnostic decisions efficiently.
Q: What are the recommended storage conditions for the CLIA analyzer's reagents and components?
A: All reagents and components should be stored at 2 to 8C to ensure reagent stability and optimal analyzer performance. Deviations from these conditions may affect test accuracy.
Q: When should the ZYBIO EXI ProGRP (CLIA) be used in a laboratory setting?
A: The analyzer is recommended for use during routine or specialized laboratory testing that requires the precise determination of ProGRP, which is valuable in diagnosing and monitoring certain clinical conditions.
Q: Where can the ZYBIO EXI ProGRP (CLIA) analyzer be installed and operated?
A: This portable analyzer is ideal for laboratory installations across various healthcare and diagnostic facilities in India. Its compact design does not support wall mounting, promoting flexible placement on stable surfaces.
Q: What is the operational process of the CLIA analyzer?
A: The process is automated: operators load the specimens and reagents, and the analyzer performs the assay, providing real-time results with minimal hands-on time required.
Q: Who can benefit from using the ZYBIO EXI ProGRP (CLIA) analyzer?
A: Laboratories, dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers in India gain from its reliable diagnostics, robust automation, and efficient workflow integration.
Q: What are the primary advantages of using a Chemiluminescence Immunoassay for ProGRP testing?
A: CLIA technology offers rapid, sensitive, and precise quantification of ProGRP, improving the reliability of test outcomes and enhancing patient care strategies.